A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Advanced Ovarian Cancer
Interventions: OTHER: None (Observational Study)
Sponsor: AstraZeneca
Collaborators: Merck Sharp & Dohme LLC